- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02162238
Assessment of Zinc Intake From Enriched Water and Other Dietary Sources in Kisumu, Kenya
Introduction: The prevalence of low serum zinc in children under 5 in East Seme, Kisumu is 73.5% and this is likely due at least in part to low bioavailable zinc from the local cereal-based diet. Interventions that will increase zinc intake could prove useful in the effort to control zinc deficiency. A potential strategy is to increase zinc intake through enriched or fortified water. The Life Straw Family filter (LSF, Verstergaard Frandsen S.A, Switzerland) is capable of purifying water and at the same time enriching it with zinc at a variable concentration with mean delivery of approximately 1-4mg/L.
Aims of the study: The primary aim of this study will be to quantify in under 5 year old children the contribution of the household LSF device to zinc intake and dietary zinc bioavailability in participating households. Secondary objectives are; 1) to assess change in serum zinc levels, growth, morbidity in the intervention group compared to control; 2) to characterize composition of the intestinal flora of children in the intervention group compared to control.
Study Design and Methods:
Consenting households from East Seme, Kisumu, Kenya will be randomly allocated to 2 treatment arms in an effectiveness study (90 under-five's per treatment arm). Group one will receive the LSF device with the zinc delivery system; group 2 will receive a LSF without the zinc delivery system.
Zinc intake will be assessed in a subsample of the under 5 year old children enrolled in the effectiveness trial (n=100). This will be estimated by 24 hr recalls administered on 2 non-consecutive days in the dry and wet season. Selected food samples will be collected for direct analysis of zinc and phytic acid content, to supplement data from food composition tables (FCT's). The dietary assessment data will be used to estimate the distribution of zinc intakes in this age group and the EAR cut-off method will be used to estimate the proportion at risk of inadequate intakes.
Data on water intake from the LSF device will be obtained by personal diaries and tally counters. The Zn concentration of the filtered water will be measured weekly. Using these data and the data from the dietary assessment, the contribution of the LSF zinc delivery to the overall dietary zinc intake will be estimated.
The effectiveness study will be conducted as a 6-month double blind randomised trial with 3 assessment time points (baseline, midpoint and endpoint). Three ml (3ml) whole blood will be collected from under 5 year old children enrolled in the households for determination of serum zinc (SZn), C-reactive protein (CRP), Alpha-1- acid glycoprotein (AGP) and hemoglobin (Hb). Stool samples will be collected from a subsample at baseline, midpoint and endpoint in the intervention and control group to assess the composition of the gut microflora and gut inflammation. Anthropometrics (weight and height) will be measured at baseline, midpoint and endpoint of the study. Weekly active surveillance for incidence and severity of malaria, diarrhea and other infectious diseases will be done by questionnaire.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Nyanza
-
Kisumu, Nyanza, Kenya
- Maseno University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children (under 5 year olds) in consenting households will participate in the study
Exclusion Criteria:
- Subjects with severe anemia (Hb<7g/dl)
- Subjects receiving zinc supplementation
- Subject with chronic diseases affecting zinc metabolism, such as kidney diseases or chronic gastrointestinal disease.
- Subjects participating in any other clinical trials in the study site
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: purified water
Filtered water Pump water purified by the LSF-filtering device Intervention: Device: LSF-filtering device
|
|
Experimental: zinc enriched purified water
Zinc water water purified and zinc-enriched by the LSF-filtering device Intervention: Device: LSF-filtering device
|
Device: LSF-filtering device LifeStraw Family is a water purification device that by means of hollow fibres removes solid particles (<0.5 Nephelometric Turbidity units turbidity reduction), bacteria (>Log 6 reduction), viruses (>Log 4 reduction) and cysts (>Log 3 reduction).
Zinc enrichment is provided by a chamber housing a zinc releasing glass-plate that is placed annexed to the hollow fibre column.
It is estimated that the LSF can provide about 5 mg of zinc/l of filtered water.
By consuming daily a portion of 0.6 litres of enriched water, >100% of the age-specific estimated physiologic requirement would be covered, assuming a fractional absorption of 40%.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
number of participants with adequate zinc intake above the EAR (estimated average requirement)
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
number of participants with increased serum zinc level from baseline
Time Frame: at 3 months into intervention and at 6 months
|
at 3 months into intervention and at 6 months
|
morbidity incidence
Time Frame: every week up to 24 weeks
|
every week up to 24 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Michael B Zimmerman, PhD, ETH Zurich and Wageningen University
- Study Director: Pauline Andango, PhD, Maseno University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Zinc Deficiency
-
NobelpharmaCompleted
-
Swiss Federal Institute of TechnologyHarvestPlusCompleted
-
Prof. Michael B. ZimmermannUniversité d'Abomey-CalaviCompleted
-
University of California, DavisHelen Keller International; Cheikh Anta Diop University, Senegal; Global Alliance...Completed
-
NobelpharmaCompleted
-
International Centre for Diarrhoeal Disease Research...University of California, DavisCompleted
-
University of California, DavisHelen Keller International; Université Polytechnique de Bobo-Dioulasso; NutrisetCompletedZinc DeficiencyBurkina Faso
-
Swiss Federal Institute of TechnologyHarvestPlusCompletedZinc Deficiency
-
University of California, DavisUSDA, Western Human Nutrition Research CenterCompleted
-
University of California, DavisHelen Keller International; Cheikh Anta Diop University, Senegal; Global Alliance...Completed
Clinical Trials on LSF-filtering device
-
Prof. Michael B. ZimmermannUniversité d'Abomey-CalaviCompleted
-
University of the Balearic IslandsCompletedCovid19 | Personal Protective EquipmentSpain
-
University of RegensburgCompleted
-
Medical University of ViennaCompleted
-
University of South BohemiaCompletedRespiratory Complication | Face Mask SqueezeCzechia
-
Swiss Federal Institute of TechnologyUniversity of ZurichCompleted
-
Universidad Complutense de MadridCompletedMasks | Community Health Workers | FiltrationSpain
-
Barcelona Institute for Global HealthRecercaixa; Centre de Recerca per a l'Educació Científica i Matemàtica (CRECIM) and other collaboratorsCompletedRisk Behavior | Attention Impaired | Risk-Taking | Social Preferences | Decision Making | AttentionSpain
-
The Hong Kong Polytechnic UniversityCompleted
-
Fudan UniversityCompletedInflammation | Blood Coagulation Disorders | Blood Pressure | Vasoconstriction | Autonomic Nervous System ImbalanceChina